According to our results presented here and data published previously by others [16,17,18], WT1 isoforms are expressed in malignant myeloid blasts derived from patients with AML and CML at constant ratios with a predominant expression observed for WT1+/+. The gene discussed is WT1; the disease is acute myeloid leukemia.